Palatin Technologies
PTN
#10903
Rank
โ‚ฌ10.56 M
Marketcap
5,93ย โ‚ฌ
Share price
-3.60%
Change (1 day)
-45.97%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -โ‚ฌ7.25 Million

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚ฌ13.18 Million. In 2025 the company made an earning of -โ‚ฌ8.69 Million, an increase over its 2024 earnings that were of -โ‚ฌ24.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ7.25 Million-16.56%
2025 -โ‚ฌ8.69 Million-64.29%
2024 -โ‚ฌ24.33 Million-16.9%
2023 -โ‚ฌ29.28 Million5.99%
2022 -โ‚ฌ27.63 Million-13.7%
2021 -โ‚ฌ32.01 Million33.25%
2020 -โ‚ฌ24.02 Million-172.11%
2019 โ‚ฌ33.3 M2352.33%
2018 โ‚ฌ1.35 M-94.13%
2017 โ‚ฌ23.14 M-154.92%
2016 -โ‚ฌ42.14 Million3.67%
2015 -โ‚ฌ40.65 Million878%
2014 -โ‚ฌ4.16 Million-72.64%
2013 -โ‚ฌ15.2 Million-33.11%
2012 -โ‚ฌ22.72 Million77.71%
2011 -โ‚ฌ12.78 Million
2003 -โ‚ฌ21.64 Million29.93%
2002 -โ‚ฌ16.66 Million36.18%
2001 -โ‚ฌ12.23 Million
1999 -โ‚ฌ10.16 Million6.04%
1998 -โ‚ฌ9.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ16.90 B-223,736.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ13.62 B-180,349.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ0.77 B-10,409.19%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚ฌ9.71 Million 28.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ55 M-827.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion 1,305.44%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ0.14 B-1,985.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚ฌ26.63 Million 252.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ49.91 Million 560.06%๐Ÿ‡บ๐Ÿ‡ธ USA